Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan-Feb;34(1):100-8.
doi: 10.3747/pdi.2012.00149. Epub 2013 Sep 1.

Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics

Affiliations

Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics

Cécile Courivaud et al. Perit Dial Int. 2014 Jan-Feb.

Abstract

Background: Previous small studies have reported favorable results of peritoneal dialysis (PD) in the setting of chronic refractory heart failure (CRHF). We evaluated the impact of PD in a larger cohort of patients with CHRF where end-stage renal disease was excluded. ♢

Methods: All patients who received PD therapy for CRHF between January 1995 and December 2010 in two medical centers in France were included in this retrospective study. Baseline characteristics were compared with clinical parameters during the first year after initiation of PD. Mortality, safety, and sustainability of PD were also analyzed. ♢

Results: The 126 patients included had a mean age of 72 ± 11 years and an estimated glomerular filtration rate of 33.5 ± 15.1 mL/min/1.73 m2. Mean time on PD was 16 ± 16.6 months. During the first year, patients with a left ventricular ejection fraction (LVEF) of 30% or less experienced improvement in cardiac function (30% ± 10% vs 20% ± 6%, p < 0.0001). We observed a significant reduction in the number of days of hospitalization for acute decompensated heart failure after PD initiation (3.3 ± 2.6 days/patient-month vs 0.3 ± 0.5 days/patient-month, p < 0.0001). One-year mortality was 42%. ♢

Conclusions: In CRHF, PD significantly reduces the number of days of hospitalization for acute heart failure. Improved LVEF may have led to the comparatively good 1-year survival in this cohort.

Keywords: Cardiorenal syndrome; cardiac failure; impaired renal function; ultrafiltration.

PubMed Disclaimer

Figures

Figure 1 —
Figure 1 —
(A) Left ventricular ejection fraction (LEVF) improved after peritoneal dialysis (PD) therapy in the study population. (B) Patients with better cardiac function did not have a major change in ejection fraction, (C) but those with a low ejection fraction experienced significant improvement.
Figure 2 —
Figure 2 —
Kaplan-Meier analysis of survival after initiation of peritoneal dialysis (PD) in (A) the entire study population, (B) renal function groups, and (C) cardiac function groups. Although glomerular filtration did not affect mortality, patients with a moderate reduction in left ventricular ejection fraction (LVEF) had a better survival rate. eGFR = estimated glomerular filtration rate; NS = nonsignificant.
Figure 3 —
Figure 3 —
Kaplan-Meier analysis of survival after initiation of peritoneal dialysis (PD) by (A) treatment period (before and after 2003), and for the same two periods by (B) estimated glomerular filtration rate (eGFR) and (C) left ventricular ejection fraction (LVEF). NS = nonsignificant.

References

    1. Norton C, Georgiopoulou VV, Kalogeropoulos AP, Butler J. Epidemiology and cost of advanced heart failure. Prog Cardiovasc Dis 2011; 54:78–85 - PubMed
    1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. on behalf of the ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10:933–89 [Erratum in: Eur J Heart Fail 2010;12:416; dosage error in article text: Eur J Heart Fail 2009; 11:110] - PubMed
    1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007–18 - PubMed
    1. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209–16 - PubMed
    1. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: “Guyton revisited.” Eur Heart J 2005; 26:11–17 - PubMed

LinkOut - more resources